Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro (Q40571040)
scientific article published on April 2004
Language:
(P31) (Q13442814)
(P50) (Q112045947)
(P304) 2333-2337
(P407) (Q1860)
(P433) 7
(P478) 64
(P577) Thursday, April 1, 2004
(P921) (Q27114666)
(Q177094)
(P1433) (Q326097)
(P1476) "Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro" (language: en)
(P2093) Glen S Germain
Franklin C Harwood
John D Schuetz
Clinton F Stewart
Elisabeth Buchdunger
Peter Traxler
other details
description scientific article published on April 2004

External Links